Women’s Health – Q1 2022 Acquisition Activity and Outlook
The first quarter of 2022 delivered six reported Women's Health transaction, marking a sharp increase in transaction activity compared to the end of last year.
Urology – Q1 2022 Acquisition Activity and Outlook
The first quarter of 2022 delivered three reported urology practice acquisitions, continuing a pattern of smaller deal volume and larger deal size when compared to other practice specialties undergoing M&A consolidation.
Orthopedics – Q1 2022 Acquisition Activity and Outlook
The 1st quarter of 2022 delivered nine reported orthopedic practice acquisitions, continuing the trend of increasing deal volume.
Home Health & Hospice – Q1 2022 Acquisition Activity and Outlook
The first quarter of 2022 delivered twenty-eight reported home health and hospice acquisitions, coming down from peaks levels to end the past year However, Q1 has historically brought lower M&A levels, and we expect deal volume to rebound throughout the year.
Gastroenterology – Q1 2022 Acquisition Activity and Outlook
The first quarter of 2022 delivered ten reported gastroenterology practice acquisitions, continuing the high level of M&A activity we saw last year Several deals were announced in the first few weeks of the year, likely spilling over from efforts to close in 2021.
ENT & Allergy – Q1 2022 Acquisition Activity and Outlook
The first quarter of 2022 delivered two reported ENT practice acquisitions, coming down from a flurry of deal activity to end last year.
Dermatology – Q1 2022 Acquisition Activity and Outlook
The 4th quarter of 2021 delivered two reported cardiology platform acquisitions, signaling an imminent wave of increasing private equity investments into the specialty.
Behavioral Health – Q1 2022 Acquisition Activity and Outlook
The first quarter of 2022 delivered thirty-five reported behavioral health acquisitions, returning to average deal volume after a spike in activity to end 2021. Mental health and addiction treatment continue to be at the forefront of consolidation. We will highlight a few notable deals from the period.
Cardiology – Q1 2022 Acquisition Activity and Outlook
The 1st quarter of 2022 delivered two reported cardiology partnerships for this specialty in the Early Pioneering lifecycle stage PE interest remains consistent and seems to be building
